alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-7479

KARLOS S. DAVIS,

Petitioner - Appellant,

versus

MARK HENRY, Warden; FEDERAL BUREAU OF PRISONS,

Respondents - Appellees.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. Marvin J. Garbis, District Judge. (CA-98-

1642-MJG)

Submitted: March 23, 1999 Decided: July 9, 1999

Before ERVIN, WILKINS, and NIEMEYER, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Karlos S. Davis, Appellant Pro Se. Lynne Ann Battaglia, United

States Attorney, George Levi Russell, III, OFFICE OF THE UNITED

STATES ATTORNEY, Baltimore, Maryland, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Karlos S. Davis appeals from a district court order denying

relief on his 28 U.S.C. § 2241 (1994) petition. In his petition,

Davis asserted that the Bureau of Prisons (BOP) erred in finding

him ineligible for a sentence reduction under 18 U.S.C.A. §

3621(e)(2) (West Supp. 1998). The BOP found Davis did not qualify

for the reduction because his offense was considered “violent”

under its interpretation of § 3621(e)(2). The district court initially granted Davis’ petition and ordered the BOP to reconsider

his eligibility for sentence reduction. It then granted the Government’s motion to alter or amend its judgment under Fed. R. Civ.

P. 59(e) based upon our intervening decision in Pelissero v.

Thompson, 155 F.3d 470 (4th Cir. 1998), withdrawn and reh’g

granted, 1998 WL 971397 (4th Cir. Nov. 27, 1998) (No. 97-6156), on

rehearing, ___ F.3d ___, 1999 WL 133112 (4th Cir. Mar 12, 1999)

(Nos. 97-6156, 97-6221). See Collison v. International Chem.

Workers Union, Local 217, 34 F.3d 233, 236 (4th Cir. 1994). Our

review of the record discloses that the district court committed no

reversible error.

Accordingly, we affirm the district court’s denial of Davis’

petition. We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

AFFIRMED
# Fourth Court of Appeals

San Antonio, Texas

December 27, 2016

No. 04

- 16

- 00014

- CR

Robert Adrian RENDON,

Appellant

v.

The State of TEXAS,

Appellee

From the 227th Judicial District Court, Bexar County, Texas

Trial Court No. 2015CR11270

Honorable Kevin M. O'Connell, Judge Presiding



### O R D E R

Appellee ’ s motion for extension of time to file their brief is granted. The appellee ’ s brief

is due on January 13, 2017.

_________________________________ Marialyn Barnard, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 27th day of December, 2016

.

___________________________________ Keith E. Hottle

Clerk of Court
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          OCT-31-1995
<PERIOD-START>                             NOV-01-1994
<PERIOD-END>                               OCT-31-1995
<CASH>                                           4,013
<SECURITIES>                                         0
<RECEIVABLES>                                    1,435
<ALLOWANCES>                                         0
<INVENTORY>                                     19,396
<CURRENT-ASSETS>                                25,361
<PP&E>                                           4,818
<DEPRECIATION>                                     871
<TOTAL-ASSETS>                                  29,717
<CURRENT-LIABILITIES>                           15,953
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            75
<OTHER-SE>                                      13,341
<TOTAL-LIABILITY-AND-EQUITY>                    29,717
<SALES>                                         70,029
<TOTAL-REVENUES>                                70,029
<CGS>                                           56,872
<TOTAL-COSTS>                                   56,872
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,336
<INCOME-PRETAX>                                  2,439
<INCOME-TAX>                                       980
<INCOME-CONTINUING>                              1,459
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,459
<EPS-PRIMARY>                                      .20
<EPS-DILUTED>                                      .20
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED STATEMENTS OF OPERATIONS FOR WOLVERINE TUBE, INC. FOR THE TWELVE
MONTHS ENDED DECEMBER 31, 1999 AND THE CONSOLIDATED BALANCE SHEET AT DECEMBER
31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          26,894
<SECURITIES>                                         0
<RECEIVABLES>                                   84,440<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                     95,368
<CURRENT-ASSETS>                               217,628
<PP&E>                                         190,774<F1>
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 506,689
<CURRENT-LIABILITIES>                           67,481
<BONDS>                                        176,421
<PREFERRED-MANDATORY>                            2,000
<PREFERRED>                                          0
<COMMON>                                           142
<OTHER-SE>                                     222,808
<TOTAL-LIABILITY-AND-EQUITY>                   506,689
<SALES>                                        645,774
<TOTAL-REVENUES>                               645,774
<CGS>                                          579,030
<TOTAL-COSTS>                                  579,030
<OTHER-EXPENSES>                                52,656
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              12,608
<INCOME-PRETAX>                                  1,480
<INCOME-TAX>                                      (289)
<INCOME-CONTINUING>                              1,769
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                       (5,754)
<NET-INCOME>                                    (3,985)
<EPS-BASIC>                                      (0.33)
<EPS-DILUTED>                                    (0.32)
<FN>
<F1>THE VALUES FOR TAGS RECEIVABLES AND PP&E ARE SHOWN NET OF THEIR RESPECTIVE
ALLOWANCE ACCOUNTS.
</FN>


</TABLE>
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1433 Introduced in Senate (IS)]

105th CONGRESS
  1st Session
                                S. 1433

         To suspend temporarily the duty on a certain chemical.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 7, 1997

   Mr. Helms introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
         To suspend temporarily the duty on a certain chemical.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SUSPENSION OF DUTY.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:
    

         ``    9902.30.90     3-amino-2-                                                                        
                               (sulfato-ethyl                                                                   
                               sulfonyl) ethyl                                                                  
                               benzamide (CAS                                                                   
                               No. 121315-20-6)                                                                 
                               (provided for in                                                                 
                               subheading                                                                       
                               2930.90.29).....  Free        No change        No change       On or before      
                                                                                               12/31/2000       
                                                                                                              ''

    (b) Effective Date.--The amendment made by this section applies to 
articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of enactment of this Act.
                                 <all>
```
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1452 Introduced in Senate (IS)]

105th CONGRESS
  1st Session
                                S. 1452

       To suspend until January 1, 2001, the duty on a chemical.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 7, 1997

   Mr. Helms introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
       To suspend until January 1, 2001, the duty on a chemical.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SUSPENSION OF DUTY.

    Subchapter II of chapter 99 of the Harmonized Tariff Schedule of 
the United States is amended by inserting in numerical sequence the 
following new item:

      

``    9902.32.44     Benzenesulfonic                                                                            
                      acid, 2,2-(1,2-                                                                           
                      ethenediyl)bis                                                                            
                      [5-nitro- (CAS                                                                            
                      No. 128-42-7)                                                                             
                      (provided for in                                                                          
                      subheading                                                                                
                      2904.90.35.00)..  Free              No change        No change        On or before 12/    
                                                                                             31/2000            
                                                                                                              ''

SEC. 2. APPLICABILITY.

    The amendment made by section 1 applies with respect to goods 
entered, or withdrawn from warehouse for consumption, on or after the 
15th day after the date of enactment of this Act.
                                 <all>
```
<PAGE>   1
                                                                      Exhibit 99


SNODGRASS
Certified Public Accountants


                        REPORT OF INDEPENDENT ACCOUNTANTS


To the Board of Directors
  and Shareholders of
  Tuscarora Incorporated

We have audited the accompanying consolidated balance sheets of Tuscarora
Incorporated and subsidiaries as of August 31, 1996 and 1995, and the related
consolidated statements of income, shareholders' equity and cash flows for the
years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of
material missstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of Tuscarora
Incorporated and subsidiaries as of August 31, 1996 and 1995, and the results
of their operations and their cash flows for the years then ended, in
conformity with generally accepted accounting principles.


                                             /s/ S.R. SNODGRASS, A.C.
                                             ----------------------------------
                                                 S.R. Snodgrass, A.C.

Beaver Falls, PA
October 11, 1996



     S.R. Snodgrass, A.C.
     110 Central Square Drive  Beaver Falls, PA 15010-7302  Phone: 412-843-4920
                                                        Facsimile: 412-847-5048
[Federal Register Volume 86, Number 153 (Thursday, August 12, 2021)]
[Notices]
[Pages 44405-44406]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17181]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-875]


Importer of Controlled Substances Application: Globyz Pharma, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Globyz Pharma, LLC. has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

[[Page 44406]]


DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before September 13, 
2021. Such persons may also file a written request for a hearing on the 
application on or before September 13, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on May 7, 2021, Globyz Pharma, LLC., 2101 Market Street, 
Suite 5, Upper Chichester, Pennsylvania 19061-4001, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Lisdexamfetamine.......................     1205  I
------------------------------------------------------------------------

    The company plans to import finished dosage unit products of 
Lisdexamfetamine for the one time need of analytical testing. No other 
activity for this drug codes is authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-17181 Filed 8-11-21; 8:45 am]
BILLING CODE P
Minute Grder Farm (06/97)

United States District Court, Northern District of Llinois

Name of Assigned Judge Paul E. Plunkett Sitting Judge if Other Tan H. Levin
or Magistrate Judge ° than Assigned Judge
CASE NUMBER 02 C 8163 ‘DATE 1/29/2003
CASE IL District Council vs. Silvino Tinajero
TITLE :
[ln the following box (a) indicate the party filing the motion, c.g. plaintiff, defendant, 3rd party plaintiff, and (b) state briefly the nature
MOTION: of the motion being presented.]
Plaintiff's motion for default judgment and entry of final order
DOCKET ENTRY:
ql) | Filed motion of [ use listing in “Motion” box above.]
(2) a Brief in support of motion due
(3) Oo Answer brief to motion due. . Reply to answer bricFdue_
{4) o Ruling/Hearing on... set for at
(5) ag Status hearing[held/continued to} [set for/re-set for] on set for at
(6) ag Pretrial conference[held/continued to] [set for/re-set for] on__ set for at
(7) a Trial{set for/re-set for] on at
(8) Oo [Bench/Jury triad] [Hearing] held/continued to at
(9) qo This case is dismissed [with/without] prejudice and without costs[by/agreement/pursuant to]
OOFRCP4(m) ClLocal Rule 41.1 COFRCP4I1 (a1) O FREP41(a)(2).
do «Ooi [Other docket entry] Enter report and recommendation recommending that plaintiff's motion
for default judgment and entry of final order be granted and, accordingly, it is recommended that
the order attached hercto be entered by the District Judge.
dl) ff [For further detail see order on the reverse side of the original minute order.]
No notices required, advised imwopen court. Document
No notices required. Number
umber of nviggs
Notices mailed by judge's stat. JAN 3.0 2003
Notified counsel by telephone oceted
wv | Docketing to mail notices, Lae
Mail AO 450 form. hel X Tbe ae)
| Copy to judge/magistrate judge.
courtroom: at snore
SM deputy’s
initial
TM“ Datkaimeleddived io si
central Clegk's Office vwiting dept initials



“(Reserved for use by the Court)

ORDER

Any objections to this Report and Recommendation must be filed with the Clerk of the Court within ten
(10) day of receipt of this notice. Failure to file objections within the specified time waives the right to
appear on the Magistrate Judge’s Report and Recommendation. See Fed. R. CIV. P. 72 (B); 28 U.S.C,
636(B)(1)(B); LORENTZEN v. ANDERSON PEST/CONTROL, 64 F.3D 327, 329 (7TM CIR. 1995); THE
PROVIDENT BANK v. MANOR STELL CORP., 882 F.2D 258 (7" CIR 1989).
----

**Exhibit 32.1**

CERTIFICATION PURSUANT TO THE SARBANES-OXLEYACT 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

I, John L. Threshie Jr., CEO of The TirexCorporation (the "Company") do hereby certify, pursuant to 18 U.S.C. Section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that, to my knowledge: 

1. This Annual Reporton Form 10-KSB of the Company for the period ended June 30, 2008 as filed withthe Securities and Exchange Commission (the "report"), fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;and 

2. The information contained in thereport fairly presents, in all material respects, the financial condition andresults of operations of the Company. 

 

/s/_John L. Threshie Jr._____ John L. Threshie Jr., CEO 

Date: October 14, 2008 

 

----
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION (IN THOUSANDS) EXTRACTED
FROM ILEX ONCOLOGY, INC.'S BALANCE SHEET AS OF DECEMBER 31, 1997, AND ITS
STATEMENT OF OPERATIONS FOR THE YEAR THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          22,655
<SECURITIES>                                    19,991
<RECEIVABLES>                                    4,775
<ALLOWANCES>                                     (123)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                38,138
<PP&E>                                           3,121
<DEPRECIATION>                                   (562)
<TOTAL-ASSETS>                                  55,311
<CURRENT-LIABILITIES>                            3,802
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           123
<OTHER-SE>                                      50,953
<TOTAL-LIABILITY-AND-EQUITY>                    55,311
<SALES>                                              0
<TOTAL-REVENUES>                                12,861
<CGS>                                                0
<TOTAL-COSTS>                                   12,420
<OTHER-EXPENSES>                                11,706
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (2,583)
<INCOME-PRETAX>                                (8,682)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (8,682)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,682)
<EPS-PRIMARY>                                   (0.72)
<EPS-DILUTED>                                   (0.72)


</TABLE>